Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q2 2023 Earnings Call Transcript August 3, 2023
Alnylam Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-2.21 EPS, expectations were $1.72.
Operator: Good day and thank you for standing by. Welcome to the Alnylam Pharmaceuticals Q2 2023 Earnings Conference Call. At this time, participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please...
